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As my Sept. 14 retirement date approached, I’m found myself
wondering more often about how I will adjust to and enjoy
retirement. Will it be a period of life marked by peace, relaxation and
leisure time, as I hope, or will it be a change fraught with regret 
and anxiety? Contrary to commonly held opinion, studies have shown
that most physicians do well in retirement and that it is only a small
percentage of physicians who struggle with the loss of a sense of
purpose or diminished self-image. Because most retiring physicians
have good health and adequate income (prime factors in successful
retirement), and typically have numerous varied opportunities for
involvement in post-retirement activities (especially non-medical ones),
it turns out that most fears of retirement are unfounded.
Although I’m somewhat uncertain as to what retirement will bring, 
I’m convinced that it will afford me a chance to adopt a different view
of life — a view that is slower, gentler, more peaceful, yet interesting
and fulfilling — a life filled 
with new opportunities 
for exploring, for doing 
and for being. A year 
from now when I reflect 
back on this message, 
I trust I’ll be able to 
say, “I’ve never been 
so happy and content. 





By Allen Horn, MD, MBA, FACPE 
President, CentraCare Clinic
Caring for generations ...
CentraCare Clinic’s Medical Director David Tilstra, MD,
moved into the role of CentraCare Clinic President Sept. 1. 
Dr. Tilstra started with CentraCare Clinic in 1995 and
worked in both Pediatrics and Genetics. When he became
CentraCare Clinic’s Medical Director in January 2003, he
continued to work part-time in the Genetics Clinic — as he
will as Clinic President. Dr. Tilstra is a graduate of the
University of Iowa College of Medicine. He completed 
a pediatric residency at the University of
Iowa Hospitals and Clinics, and a fellowship
in medical genetics at the University of
Washington in Seattle. He is board certified
in pediatrics and medical genetics. In his
role as Medical Director, Dr. Tilstra has
become a recognized leader in health care
quality improvement. 
Meet our new Clinic President
David Tilstra, MD
Bariatric Surgery     CentraCare Clinic - River Campus, (320) 240-2828
Sayeed Ikramuddin, MD
Medical School: Albany Medical College, Albany, NY
Residency: Surgery, SUNY Health Sciences Center, Syracuse, NY
Fellowship: Advanced Laparoscopic Surgery, Ohio State University, Columbus, OH; Minimally Invasive
Surgery, University of Pittsburgh, Pittsburgh, PA
Board Certified: Surgery
Clinical Interests: Minimally invasive general surgery, effects of gastric bypass on type 2 diabetes mellitus
Girish Luthra, MBBS
Medical School: University of Ibadan College of Medicine, Ibadan, Nigeria
Residency: General Surgery, University of North Dakota, Grand Forks, ND
Fellowship: Minimally Invasive Surgery and Bariatrics, Geisinger Medical Center, Danville, PA
Board Certified: General Surgery
Partners: Scott G. Houghton, MD Kurt Martinson, MD Nathan Reuter, MD
James Lundeen, MD Matthew Maunu, MD Stephen Sahlstrom, MD
Maria Mallory, MD Paul Mitchell, MD Christian Schmidt, MD
Introducing our new CentraCare Clinic Specialists
Electrophysiology     Central Minnesota Heart & Vascular Center, (320) 656-7020
John Schoenhard, MD, PhD
Medical School: Vanderbilt University School of Medicine, Nashville, TN
Residency: Internal Medicine, John Hopkins Hospital, Baltimore, MD
Fellowship: Cardiology, Vanderbilt University School of Medicine, Nashville, TN; Electrophysiology,
Stanford University Medical Center, Stanford, CA
Board Certified: Internal Medicine and Cardiovascular Disease
Clinical Interests: Complex ablation therapy and implantable defibrillator placement
Partners: Ann Dunnigan, MD Keith Lurie, MD Simon Milstein, MD Mevan Wijetunga, MD
General Surgery     CentraCare Clinic – River Campus, (320) 252-3342
Jolene Singh, MD
Medical School: University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND
Residency: General Surgery, Hennepin County Medical Center, Minneapolis
Board Eligible: Surgery
Clinical Interests: Anorectal and breast procedures
Partners: Scott G. Houghton, MD Kurt Martinson, MD Nathan Reuter, MD
James Lundeen, MD Matthew Maunu, MD Stephen Sahlstrom, MD
Maria Mallory, MD Paul Mitchell, MD Christian Schmidt, MD
Internal Medicine     CentraCare Clinic – Health Plaza, (320) 229-4928
Camelia Florea, MD
Medical School: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Residency: Internal Medicine, New York Hospital Medical Center of Queens, Flushing, NY
Board Certified: Internal Medicine
Clinical Interests: Women’s health, preventive medicine, chronic disease management
Partners: Angelina Ausban, MD Patricia Nee, MD
David Furda, MD Xiaofang Sheng-Tanner, MD
Leah Holmgren, MD
Introducing our new CentraCare Clinic Specialists
Internal Medicine     CentraCare Clinic - River Campus, (320) 240-2203
Tiffany Rickbeil, MD
Medical School: University of Texas Southwestern Medical Center, Dallas, TX
Residency: Internal Medicine, Baylor University Medical Center, Dallas, TX
Board Eligible: Internal Medicine
Partners: Barbara J. Bollinger, MD John Johnson, MD Thomas Nardi, MD Sharon Ruggiero, MD
Denise Guanzon, MD W. Leland Lindquist, MD Christine Reichl, MD Ying Zhou, MD
Dinesh Hindka, MBBS Lynn McFarling, MD Stephen Reichl, MD
Oluyemi Ajayi, MD
Medical School: College of Health
Sciences, University of Ilorin, Ilorin,
Nigeria
Residency: Internal Medicine, 
St. Francis Hospital, Evanston, IL
Board Certified: Internal Medicine
Jessie Roske, MD
Medical School: University of Minnesota,
Minneapolis
Residency: Internal Medicine, University
of Minnesota, Minneapolis
Fellowship: Vascular Medicine, Ochsner
Clinic, New Orleans, LA
Board Eligible: Internal Medicine
Travis Williams, MD
Medical School: University of 
North Dakota School of Medicine 
and Health Science, Grand Forks
Residency: Internal Medicine,
University of Iowa Hospitals and Clinics,
Iowa City
Fellowship: Ochsner Clinic, New
Orleans, LA
Board Eligible: Internal Medicine
Hospitalist     CentraCare Clinic – River Campus, (320) 250-2678
Partners: Olayiwola Adetunji, MD Eric McFarling, MD
Hanadee Alameldin, MBBS Joseph Mercuri, MD
Christopher Aronson, MD Ravikanth Nathani, MBBS
Rebecca Campbell, MD Brian Nelson, MD
Sarah Carter, MD Holly Peterson, MD
Darren Chihos, MD Todd Severnak, DO
Arihant Dalal, MD Shweta Sharma, MD
Ghassan Elkadi, MD Mary Joy Sia Su, MD
Shari Haroldson, MD Walter Sia Su, MD
Khadir Kakal, MD Jeremy Skramsted, MD
Gemma Lim, MD Peter Waldusky, MD
Paul Marek, MD Darin Willardsen, MD
Interventional Neurology     CentraCare Clinic – River Campus, (320) 240-2829
Muhammad Fareed Suri, MD
Medical School: Quaid-e-Azam University, Islamabad, Pakistan
Residency: Neurology, University Hospitals of Cleveland, Cleveland, OH
Fellowship: Cerebrovascular Neurology, University of Medicine and Dentistry, Newark, NJ;
Endovascular Surgical Neuroradiology, University of Minnesota, Minneapolis
Board Certified: Neurology, Vascular Neurology
Partners: Iris Brossard, MD Shelly Larson-Peters, MD Kathleen Rieke, MD Lawrence Schut, MD
Thanh Dang, MD Anh Nguyen, MD James Romanowsky, MD Kevin Xie, MD
Access all CentraCare Clinic physician bios online at www.centracare.com
Introducing our new CentraCare Clinic Specialists     
Pediatrics     CentraCare Clinic – Women & Children, (320) 654-3610
David Kruse, MD
Medical School: University of Iowa College of Medicine, Iowa City
Residency: Pediatrics, University of Iowa Hospitals and Clinics, Iowa City
Board Certified: Pediatrics
Clinical Interest: Sports Medicine
Partners: Jill Amsberry, DO Geri Jacobson, MD Denise Lenarz, MD Jennifer Rogan, MD
Jon Dennis, MD, MPH Janelle Johnson, MD Cindy Melloy, MD Thomas Schrup, MD
Kelly Fandel, MD Wendi Johnson, MD Dale Minnerath, MD Sylvia Sundberg, MD
Weining Hu, MD, PhD Kathleen Kulus, MD Marilyn Peitso, MD Dove Watkin, MD
Palliative Care     CentraCare Clinic, (320) 656-7117
Paula Lindhorst, MD
Medical School: Ohio State University College of Medicine, Columbus
Residency: Family Medicine, University of Minnesota-Fairview Riverside Hospital, Minneapolis
Board Certified: Family Medicine
Board Eligible: Hospice and Palliative Medicine
Clinical Interests: Strengthening resiliency in the midst of serious illness
Partner: Merryn Jolkovsky, MD
Rheumatology     CentraCare Clinic – River Campus, (320) 240-2208
Bharath Manu Akkara Veetil, MBBS 
Medical School: M.G.R. Medical University, India
Residency: Internal Medicine, Pennsylvania Hospital, University of Pennsylvania Health System,
Philadelphia
Fellowship: Rheumatology, Mayo Clinic, Rochester, MN
Board Certified: Internal Medicine and Rheumatology
Clinical Interests: Treatment of chronic rheumatic conditions
Partners: Jurgen Craig-Muller, MD Susan Leonard, MD
Aaron Holmgren, MD Anne Wolff, MD
Obesity-related type 2 diabetes is a difficult disease to
manage. In patients who are obese, the likelihood of
reaching therapeutic targets with traditional methods as
defined by the American Diabetes Association (hemoglobin
A1c less than 7.0, LDL cholesterol less than 100, systolic
blood pressure less than 130) is directly related to the
degree of obesity. Patients with a body mass index (BMI)
greater than 40 are 50 percent less likely to achieve targets
than patients with a BMI of 30.
Bariatric surgery is effective for many patients in reducing
BMI with sustained effects 15 years following surgery. 
In prospective studies, mortality is reduced 29 percent in
comparison to controls. During the past two years, we have
seen a number of publications detailing the benefits of
bariatric surgery in obese patients with 
type 2 diabetes. More direct evidence now
comes from randomized trials directly
comparing bariatric surgery to intensive
medical management. The data are
compelling, demonstrating an impressive
reduction in hemoglobin A1c with reduction or elimination
of medications in many cases. The short-term remission 
rate appears to be approximately 42 percent following the
gastric bypass. Other procedures such as laparoscopic
adjustable banding can produce significant weight loss with
less impact on type 2 diabetes. The sleeve gastrectomy
Bariatric surgery indications for patients with diabetes
By Sayeed Ikramuddin, MD, Bariatric Surgeon, CentraCare Clinic
continued on next page
Penumbra is brain tissue around the core of an infarct where
blood supply is reduced to an extent that the neurons have
ceased to function, but is enough to keep them viable.
Clinically, this means that a patient with stroke may regain
function if the blood supply to the affected area is restored
in time. The treatment of acute stroke is focused on saving
the penumbra. Depending upon the robustness of the
collaterals, the proportion of the penumbra can range from
none to all of the affected area. How long  the penumbra will
remain viable, depends on the blood flow. The blood flow is
low in the core of the penumbra thus making it more likely
to die sooner. Although CT and MRI-based perfusion studies
can provide some idea about the blood flow to the affected
area in patients with acute stroke, the fact that neurons are
dying in the penumbra with each passing minute, makes
recanalization an emergency, regardless of the blood flow. 
Since the National Institute of Neurological Disorders and
Stroke (NINDS) tPA trial results in 1995, many other 
landmark interventions have helped us fight
the penumbra (see figure below). Results of
the two recently published trials — SWIFT
and TREVO 2 — are more encouraging than
ever.1,2 Both trials compared the efficacy 
and safety of new clot retrieval devices with
a standard mechanical thrombectomy device, the Merci
Retrieval System. In the SWIFT trial, the Solitaire device
had better recanalization rates (61% vs. 24%), and patients
were more likely to have a good outcome at three months
(58% vs. 33%). Similarly, in the TREVO 2 trial,
recanalization rates (86% vs. 60%) and three-month
outcomes (40% vs. 20%) were better with the Trevo device.
Both of these devices are now FDA approved.
Newer tools to fight the stroke are encouraging, but are 
only useful if there is still penumbra. This requires public
education for early recognition of symptoms, protocols 
for early administration of IV tPA and early endovascular
recanalization for patients with penumbra.
For stroke consultation or referral, call (320) 240-2829.
The penumbra is key in stroke treatment 
By Muhammad Fareed Suri, MD, Vascular Neurologist, CentraCare Clinic – River Campus
1. For the SWIFT Trialists. Solitaire flow restoration device versus 
the Merci Retriever in patients with acute ischaemic stroke 
(SWIFT): a randomised, parallel-group, non-inferiority trial. 
Lancet. 2012; In Press: Online.
2. For the TREVO 2 Trialists. Trevo versus Merci retrievers for 
thrombectomy revascularisation of large vessel occlusions 
in acute ischaemic stroke (TREVO 2): a randomised trial. 
Lancet. 2012; In Press: Online.
produces dramatic improvement in glycemia though 
not to the extent of the gastric bypass, but with fewer
complications. Considerable interest now exists in
examining the use of bariatric surgery in less obese (BMI
less than 35) patients with uncontrolled type 2 diabetes.
Many questions remain. Despite the reduction in mortality
from cancer and diabetes, the long-term benefit of gastric
bypass remission with type 2 diabetes remains in question.
Second, appropriate patient selection is controversial. 
The confounding presence of depression in patients with
type 2 diabetes and the recognized association of suicide
suggest that care must be taken in selecting appropriate
patients for surgery. The issue of substance abuse also 
must be considered. Additionally, increased risk of 
iron-deficiency anemia, B12 deficiency, marginal 
ulceration and bowel obstructions are concerns. 
The current indications for bariatric surgery are:
1. BMI greater than 40.
2. BMI greater than 35 for more than two years with type 2 
diabetes, significant dyslipidemia, hypertension, sleep 
apnea, polycystic ovarian syndrome (PCOS) or in patients
with significant gastroesophageal reflux disease or 
ventral hernia requiring surgical repair.
3. Psychological stability. Patients with borderline 
personality disorder, bipolar disorder and anxiety might 
be considered for less invasive procedures such as 
sleeve gastrectomy or laparoscopic adjustable banding.
4. Contraindications include: attempted suicide within 
the past five years or psychiatric admission within the 
past two years. 
For more information about bariatric surgery or 
a referral, call (320) 240-2828.
Bariatric surgery indications for patients with diabetes continued 
Figure: Timeline for Interventions of Acute Ischemic
Stroke. Type of intervention, duration in hours from
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Osteoporosis is a common disorder. Women, in particular,
are known to be at higher risk of fractures because of
osteoporosis, but determining which women are at risk has
been a substantial challenge. To determine bone mineral
density (BMD), a DEXA scan may be used, but results
aren’t able to predict future risk. Low BMD does not mean
that a patient has osteoporosis or that he or she is at a high
risk of fracture in the future. 
To address this issue, the World Health Organization (WHO)
has created a new Web-based tool to calculate a more
nuanced approach to fracture risk. The tool, known as the
FRAX, is an algorithm-based tool that attempts to refine
risk based on several personal history issues and BMD scores.
The data includes age, prior fracture history, BMI, family
history of fracture, substantial glucocorticoid or steroid use,
smoking status and alcohol use. The tool calculates a 10-year
risk of fracture; the one-year risk simply divides the 10-year
risk by 10. It has been evaluated in a number of populations
and there are specific versions for a number of countries.
It isn’t perfect (as can be expected in medicine) and it does
not replace clinical judgment. For example, it doesn’t have
the ability to deal with multiple fractures 
in the same individual. One could assume
that the actual risk of fracture is higher than
what the FRAX will calculate, but the
FRAX is not able to do that correction.
There also are too many limitations to 
include in this article. Vitamin D usage 
and glucocorticoid dose differences are among 
them. A significant limitation is that it is not 
valid for patients on therapy for osteoporosis. 
Despite these limitations, the FRAX score does allow 
much more nuance than the relatively crude and poorly
predictive BMD as determined by DEXA. The WHO task
force is committed to improving the calculator in the future,
but felt it was enough of a significant advance to warrant
making it available. 
The U.S. version of the FRAX is available at
www.shef.ac.uk/FRAX/tool.jsp?country=9. It also 
is available as an app on the iPhone.
New, Web-based tool helps to calculate fracture risk
By David Tilstra, MD, Medical Director, CentraCare Clinic
